Join BII on March 26, for a unique opportunity to meet CEO Emily Leproust from San Francisco-based Twist Bioscience, when she visits BioInnovation Institute.
At the event, Emily Leproust will present the future outlook of biosciences and how Twist Bioscience accelerates applications that benefit from DNA writing, from health and medical breakthroughs to environmental sustainability, to improve the lives of people around the world.
Date: Tuesday March 26, 2019
Time: 10:00 – 12:00
Venue: BioInnovation Institute, Ole Maaløes Vej 3, 2200 København N
Please note, that the event has free admittance with 100 tickets available. Please sign up quickly to secure your seat.
As of 2017, Twist Biosciences raised 190 million dollars and IPO’ed in October 2018 to raise an additional 70 million dollars in its stock market debut.
Dr. Emily Leproust is an early pioneer in the high-throughput synthesis and sequencing of DNA and are working on disrupting the process of gene synthesis to enable the exponential growth of synthetic biology applications in multiple fields including medicine, DNA data storage, agricultural biology, and industrial chemicals.
Dr. Leproust has published over 30 peer-reviewed papers—many on applications of synthetic DNA, and is the author of numerous patents. Emily Leproust was named 2015 Global Thinker by Foreign Policy Magazine.
Program
|
9:30 |
Doors open |
|
10:00 |
Dr. Emily Leproust: ‘Powering the synthetic biology revolution’ |
|
10.45 |
Q&A session |
|
11:00 |
Informal networking and closing reception |
Organized by
